Nightingale HealthNGHLF 64 3-Year ROIIC % is 64.07 as of Jun. 2025, which is 42% below its 10-year median of 110.00. GuruFocus rates NGHLF with a GF Score™ of 64/100 and a GF Value™ of $4.48. The stock has 6 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Nightingale Health ranks better than 85.78% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Nightingale Health's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 64.07%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Nightingale Health's 3-Year ROIIC % or its related term are showing as below:
NGHLF's 3-Year ROIIC % is ranked better than 85.78% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs NGHLF: 64.07
Nightingale Health (OTCPK:NGHLF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Nightingale Health 3-Year ROIIC % Related Terms
Nightingale Health 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Nightingale Health's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGHLF vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Nightingale Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nightingale Health 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nightingale Health's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Nightingale Health's 3-Year ROIIC % falls into.
Nightingale Health's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -22.379 (Jun. 2025) - -14.3406288 (Jun. 2022) )
/
( 25.563 (Jun. 2025) - 33.06 (Jun. 2022) )
=
-8.0383712
/
-7.497
=
107.22%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Nightingale Health (NGHLF) has a 3-Year ROIIC % of 64.07 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Nightingale Health and its competitors. This is 42% below median its historical median of 110.00. According to the industry distribution chart, Nightingale Health ranks #88 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 14.2%.
Is Nightingale Health's 3-Year ROIIC % too high?
Nightingale Health's current 3-Year ROIIC % of 64.07 is 42% below median its 10-year median of 110.00. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. Nightingale Health's value of 64.07 is 1751.7% above this industry median. Based on the distribution chart, Nightingale Health ranks #88 out of 619 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nightingale Health has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nightingale Health ranks #88 out of 619 companies for 3-Year ROIIC %. This places Nightingale Health in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.46. Nightingale Health's value of 64.07 is 1751.7% above this benchmark. While the company's 10-year median is 110.00 vs. the industry median of 3.46, Nightingale Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nightingale Health's current 3-Year ROIIC % of 64.07 is 1751.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Nightingale Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nightingale Health's current 3-Year ROIIC % is 64.07, which is 42% below median its own 10-year median of 110.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Nightingale Health (NGHLF) has a current 3-Year ROIIC % of 64.07. The stock's GF Value™ is $4.48, compared to a current price of $1.19 — trading 73.4% below its estimated fair value. The current 3-Year ROIIC % is 64.07, which is 42% below median its 10-year median of 110.00 and 1751.7% above the Healthcare Providers & Services industry median of 3.46. Nightingale Health's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current 3-Year ROIIC % is 64.07 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nightingale Health (NGHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued.
The current stock price of $1.19 is trading 73.4% below its estimated GF Value™ of $4.48.
Key valuation signals for NGHLF:
3-Year ROIIC %: 64.07 (42% below median its 10-year median of 110.00)
GF Value™: $4.48 vs. price of $1.19 (73.4% below fair value)
Industry Position: 1751.7% above the Healthcare Providers & Services median (#88 of 619)
No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
64GF Score
Get the complete analysis for NGHLF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGHLF has been successfully added to your 
